NCT00929331View on ClinicalTrials.gov

Immunogenicity & Safety Study of Fluviral® (2009 - 2010 Season) in Adults Aged 18 to 60 Years and Over 60 Years

PHASE3CompletedINTERVENTIONAL

Enrollment

110

Participants

Timeline

Start Date

July 11, 2009

Primary Completion Date

August 1, 2009

Study Completion Date

August 1, 2009

Conditions

Influenza, Human

Interventions

BIOLOGICAL

Fluviral®

Intramuscular injection, one dose

Trial Locations (1)

J1H 1Z1

GSK Investigational Site, Sherbrooke

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT00929331 - Immunogenicity & Safety Study of Fluviral® (2009 - 2010 Season) in Adults Aged 18 to 60 Years and Over 60 Years | Biotech Hunter | Biotech Hunter